We are live on
!
Find out more
IVMX
Institutional Venture Management XVI Portfolio holdings
AUM
$1.18M
1-Year Est. Return
156.01%
This Fund
S&P 500
This Quarter
Est. Return
+67.77%
1 Year Est. Return
+156.01%
3 Year Est. Return
+522.88%
5 Year Est. Return
+246.9%
10 Year Est. Return
–
AUM
$86.1M
AUM Growth
+$10.1M
(+13%)
Cap. Flow
-$28.5M
Cap. Flow
% of AUM
-33.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hims & Hers Health
HIMS
|
+$28.2M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$269K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.86% |
| 2 | Consumer Discretionary | 6.14% |
| 3 | Technology | 0% |
Similar funds
JBFJ
CLIC
GFWEX
YU
S3G1
SL
SGIHM
LFA
Institutional Venture Management XVI's Q1 2024 Portfolio in Review
As of Q1 2024, Institutional Venture Management XVI held 3 positions worth $86.1M, up 13% from $76M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Institutional Venture Management XVI withdrew a net $28.5M in Q1 2024, closing 1 position and reducing 1 holding. Its most notable exit was HashiCorp, Inc. Class A Common Stock, an estimated $269K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 90% a quarter earlier, followed by Consumer Discretionary and Technology.
- Institutional Venture Management XVI's biggest Q1 2024 reduction was Hims & Hers Health, cutting an estimated $28.2M.
- Institutional Venture Management XVI fully exited HashiCorp, Inc. Class A Common Stock in Q1 2024, selling an estimated $269K.
- Institutional Venture Management XVI's ten largest holdings make up 100% of its $86.1M portfolio in Q1 2024.
- Institutional Venture Management XVI opened 0 new positions and closed 1 in Q1 2024.
- Institutional Venture Management XVI's portfolio value rose 13% quarter-over-quarter to $86.1M.
Based on Institutional Venture Management XVI's 13F filing for Q1 2024, filed 15 May 2024.